Clifford Miles is a Nephrology physician affiliated with University of Nebraska Medical Center. OpenAlex indexes 49 publications with 840 citations (h-index 15); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
988102 Nebraska Medical Ctr
Unmcp Provider Services
Omaha, NE 681988102
Telephone
402-559-4015Registry record last updated 18 Dec 2013.
Clinical trials
- Differentiating Everolimus Versus Sirolimus in Combination With Calcineurin Inhibitors in Kidney Transplant Patients
Sponsor: University of Colorado, Denver
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Eurofins Viracor, LLCProgram year20251 payment
- Eurofins Viracor, Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
48.4%Beta blocker12.9%Carvedilol74%Metoprolol Tartrate17%Metoprolol Succinate10%Part D<11 patientsCalcium channel blocker11.3%Nifedipine Er74%Amlodipine Besylate26%Part D≥36 patients+ 8 more classes in this area
Metabolism & gastrointestinal
32%Corticosteroid15.9%Prednisone100%Part D≥93 patientsProton pump inhibitor7.9%Pantoprazole Sodium65%Omeprazole35%Part D≥31 patients+ 3 more classes in this area
Anti-infectives
6.2%Short-acting sulfonamides3.8%Sulfamethoxazole-Trimethoprim100%Part D≥17 patientsCytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor2.4%Valganciclovir Hcl100%Part D≥14 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Successful Living Related Kidney Transplant Alone in a Patient with Noncirrhotic Portal Hypertension
Journal of the American Society of Nephrology
2025 - Impacts of the Post-Transplant Graft Survival Performance Metric on Trends in One-Year Post-Transplant All-Cause Graft Failure Rates
American Journal of Transplantation
2025 - Investigating Barriers and Enablers to EHR Patient Portal Utilization Among Kidney Transplant Recipients: A Survey-Based Exploration
American Journal of Transplantation
2025
Similar KOLs
Other experts from the same institution or the same specialty.
James Armitage, MD
University of Nebraska Medical Center
Julie Vose, MD
University of Nebraska Medical Center
Kathleen Moore, MD
University of Nebraska Medical Center
Ted Mikuls, MD
University of Nebraska Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”